In that case, the drug company should reimburse the government for the research costs when they decide to take on the rest of the process.
But the typical case of 'public funding, private patents' is not in the drug field, it's in other fields where the researchers doing the research get the patent in their name and then sell it.
whoever funds the research should get the patent, they can then sell or license it to industry for implementation.
Posted Nov 16, 2012 1:14 UTC (Fri) by Cyberax (✭ supporter ✭, #52523)
[Link]
Why? That's the task of academia - producing new results. You can download NIH result papers and go on creating your own drug in a garage. It's not uncommon that several companies might try to use a lead from the same paper.
And the final drugs rarely look anything like the first version of drug.